纳米颗粒-联体中的间隔工程增强了瘤相关抗原的向特异性
María de Los Angeles Ramírez1, Jolie Bou-Gharios2,3, Barbara Freis1
1Université de Strasbourg, CNRS, Institut de Physique et de Chimie des Matériaux de Strasbourg (IPCMS) UMR 7504, 67087 Strasbourg, Cedex 2, France. sylvie.begin@unistra.fr.
Nanoscale
|February 4, 2025
概括
通过调整向配体和氧化铁纳米粒子 (IONPs) 之间的间距来优化纳米粒子设计,可以显著提高瘤吸收和癌症治疗疗效.
科学领域:
- 纳米技术和材料科学 材料科学
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
背景情况:
- 治疗性纳米粒子 (NP) 对于早期癌症诊断和治疗至关重要.
- 氧化铁纳米粒子 (IONPs) 是有前途的治疗药物,但实现选择性瘤向仍然是一个挑战.
- 目前的积极向策略通常会导致适度的瘤吸收 (每克注射剂量的5-7%).
研究的目的:
- 调查向配体 (TL) 和IONP之间的间隔对瘤吸收和治疗效能的影响.
- 开发一种改善瘤微环境中的纳米粒子积累和保留的策略.
- 评估功能化IONP的目标交付和治疗潜力.
主要方法:
- 合成的登德罗化IONP通过向表皮生长因子受体 (EGFR) 的质功能化.
- 描述了移植向配体 (TL) 和聚乙烯糖醇 (PEG) 链接器的密度.
- 进行了体外评估,以评估特定的向,瘤细胞的内化和光热疗效.
主要成果:
- 通过PEG链接器促进IONP和TL之间的间距,改善了向连接体的可用性.
- 与非功能化的NP相比,功能化的IONP表现出EGFR表达瘤细胞增强的特定向和内部化.
- 改善瘤向和内部化导致光热疗法疗效提高.
结论:
- 在IONP上优化链接器长度和准连接体密度对于增强瘤积累至关重要.
- 这项研究提出了一种概念证明,通过合理设计NP-ligand接口来提高theranostic纳米粒子的有效性.
- 开发的功能化的IONPs显示出更有效的向癌症诊断和治疗的潜力.
相关概念视频
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
Modified-Release Drug Delivery Systems: Site-Targeted
130
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
130
Site-Targeted Drug Delivery Systems: Polymeric Carriers
125
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
125


